Zydus Lifesciences Slapped Rs 3.28 Cr GST Demand
Mumbai: Zydus Lifesciences Limited has received a tax demand order amounting to Rs 3.28 crore from the Assistant Commissioner of State Tax, Gujarat, related to the financial year 2019-20.The order,…
Health
Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe
Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, CuraTeQ Biologics Pvt Ltd, has entered into a marketing and distribution agreement with Germany-based pharmaceutical company STADA Arzneimittel AG…
JB Chemicals Appoints Aman Mehta as MD, Expands Board with Three New Directors
Mumbai: J.B. Chemicals & Pharmaceuticals Limited has announced key changes to its board following shareholder approval via postal ballot, reinforcing its leadership structure and governance framework.The company has appointed Aman…
Semaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch Surge
New Delhi: In response to the growing demand and widespread use of Semaglutide formulations following the patent expiry of innovator products in March 2026, the Drugs Control Administration (DCA), Telangana,…
Novo Slashes Wegovy Prices Amid Lilly’s Mounjaro Surge in South African Market
Johannesburg: Novo Nordisk is cutting South African prices of its weight-loss drug Wegovy for a second time since it launched in August, local executives said on Wednesday, pointing to fierce…
UK MHRA to Allow Drug Reviews Without Animal Testing by 2026, Issues Draft Framework
Bengaluru: Britain's medicines regulator said on Wednesday it will introduce a framework by the end of 2026, which would allow drugmakers to ask a review of the data for drugs…
Enoxaparin More Effective than Heparin in Reducing Mortality in ACS, Suggests Study
Indonesia: New research has shown that enoxaparin appears more effective than Heparin in reducing mortality among patients with Acute Coronary Syndrome. However, Hypertension was identified as a significant risk factor…
STAT+: Denali Therapeutics, Corcept Therapeutics win FDA approvals
In today's Readout Newsletter, Denali and Corcept win FDA approvals, Sarepta eyes a rebound, and Allogene progresses with an off-the-shelf CAR-T.
Repeal of EPA’s Endangerment Finding: A Blow to Cancer Care
With the repeal of the 2009 Endangerment Finding–the conclusion that greenhouse gases like carbon dioxide and methane pose a threat to public health and welfare–the Environmental Protection Agency (EPA) embraces…
High Fluid Intake Alone Ineffective in Preventing Stone Recurrence: Lancet
A new study published in The Lancet revealed that an intervention promoting sustained high fluid intake did not reduce symptomatic urinary stone recurrence in patients with prior stone disease. Despite…